IMPACT OF DEXMEDETOMIDINE USE AS AN ADJUVANT ANESTHETIC IN CESAREAN SECTION UNDER SPINAL ANESTHESIA: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.56238/levv17n56-024Keywords:
Dexmedetomidine, Cesarean Section, Spinal Anesthesia, Obstetric AnesthesiaAbstract
Introduction: Cesarean section under spinal anesthesia is widely practiced due to its favorable maternal and neonatal safety profile, yet intraoperative discomfort, shivering, hemodynamic instability, and limited postoperative analgesia remain relevant clinical challenges. Dexmedetomidine, a highly selective alpha-2 adrenergic agonist, has been increasingly investigated as an intrathecal or intravenous adjuvant to spinal anesthesia in obstetric practice. Its sedative, analgesic, and sympatholytic properties suggest potential benefits in improving anesthetic quality while preserving maternal cooperation and neonatal well-being.
Objective: The main objective of this systematic review was to evaluate the impact of dexmedetomidine as an adjuvant to spinal anesthesia in cesarean section on maternal anesthetic outcomes and safety. Secondary objectives included assessing its effects on intraoperative sedation quality, hemodynamic stability, postoperative analgesia, incidence of adverse effects, and neonatal outcomes.
Methods: A systematic search was conducted in PubMed, Scopus, Web of Science, Cochrane Library, LILACS, ClinicalTrials.gov, and the International Clinical Trials Registry Platform. Randomized and non-randomized studies published within the last five years evaluating dexmedetomidine as an adjuvant to spinal anesthesia for cesarean section were included. Data were synthesized qualitatively, focusing on anesthetic efficacy, safety outcomes, and neonatal parameters.
Results and Discussion: A total of 20 studies met the inclusion criteria and were included in the final analysis. Most studies demonstrated that dexmedetomidine, administered either intrathecally or intravenously, was associated with improved intraoperative sedation, prolonged sensory and motor block duration, reduced postoperative analgesic requirements, and lower incidence of shivering. Hemodynamic effects were generally mild and manageable, and neonatal outcomes, including Apgar scores and umbilical cord blood parameters, were comparable to control groups.
Conclusion: Current evidence suggests that dexmedetomidine is a promising and safe adjuvant to spinal anesthesia in cesarean section, offering improved anesthetic quality and maternal comfort without compromising neonatal safety when used at appropriate doses.
Downloads
References
1 Sun, Y., Xu, Y., & Wang, G. N. (2015). Intrathecal dexmedetomidine as an adjuvant to bupivacaine for cesarean section: A randomized controlled trial. Journal of Anesthesia, 29(5), 684–689. https://doi.org/10.1007/s00540-015-2008-3
2 Li, Z., Tian, M., Zhang, C. Y., et al. (2015). A comparison of intrathecal dexmedetomidine and fentanyl as adjuvants to bupivacaine for cesarean section. Drug Research, 65(11), 581–586. https://doi.org/10.1055/s-0034-1382006 DOI: https://doi.org/10.1055/s-0034-1395614
3 Qi, X., Chen, D., Li, G., et al. (2016). Intrathecal dexmedetomidine improves spinal anesthesia for cesarean section compared with intrathecal morphine. Journal of Clinical Anesthesia, 33, 258–264. https://doi.org/10.1016/j.jclinane.2016.04.027 DOI: https://doi.org/10.1016/j.jclinane.2016.04.027
4 He, L., Xu, J. M., Liu, S. M., et al. (2017). Intrathecal dexmedetomidine alleviates shivering during cesarean delivery under spinal anesthesia. International Journal of Clinical and Experimental Medicine, 10(3), 4974–4981.
5 Nasseri, K., Ghodraty, M. R., Hadavi, S. M., et al. (2017). Effect of intrathecal dexmedetomidine on shivering in cesarean section under spinal anesthesia. Anesthesia and Pain Medicine, 7(2), e14312. https://doi.org/10.5812/aapm.14312
6 Bhardwaj, N., Yaddanapudi, S., Ghai, B., et al. (2017). Dexmedetomidine as an adjuvant to wound infiltration analgesia following cesarean section. Saudi Journal of Anaesthesia, 11(2), 164–169. https://doi.org/10.4103/1658-354X.203020 DOI: https://doi.org/10.4103/1658-354X.203020
7 Xia, F., Zhang, X., Wang, X., et al. (2018). Intrathecal dexmedetomidine reduces the dose of bupivacaine required for cesarean section. BMC Anesthesiology, 18(1), 102. https://doi.org/10.1186/s12871-018-0569-3 DOI: https://doi.org/10.1186/s12871-018-0528-2
8 Liu, X., Zhang, H., Sun, Y., et al. (2019). Dose–response of intrathecal dexmedetomidine combined with bupivacaine for spinal anesthesia in cesarean section. Journal of Anesthesia, 33(3), 372–379. https://doi.org/10.1007/s00540-019-02644-0
9 Wang, J., Xu, H., Liu, J., et al. (2019). Intrathecal dexmedetomidine decreases shivering during cesarean delivery under spinal anesthesia. Medical Science Monitor, 25, 8880–8886. https://doi.org/10.12659/MSM.918331
10 Tang, Y., Huang, J., Wang, Y., et al. (2020). ED50 of ropivacaine with intrathecal dexmedetomidine for cesarean delivery. Clinical Journal of Pain, 36(4), 259–265. https://doi.org/10.1097/AJP.0000000000000804 DOI: https://doi.org/10.1097/AJP.0000000000000804
11 Qian, X., Tan, H., Chen, Y., et al. (2020). Dexmedetomidine as an adjuvant to ropivacaine in transversus abdominis plane block after cesarean section. Journal of Pain Research, 13, 2305–2313. https://doi.org/10.2147/JPR.S265429
12 Khosravi, F., Forouzannia, S. K., Mousavi, S., et al. (2020). Comparison of intrathecal dexmedetomidine and fentanyl as adjuvants in spinal anesthesia for cesarean section. Anesthesia: Essays and Researches, 14(2), 282–287. https://doi.org/10.4103/aer.AER_58_20 DOI: https://doi.org/10.4103/aer.AER_58_20
13 Wang, L., Zhang, Y., Zhang, C., et al. (2020). Perioperative dexmedetomidine improves recovery quality after cesarean section. BMC Anesthesiology, 20(1), 272. https://doi.org/10.1186/s12871-020-01178-6
14 Sween, M., Abouleish, A., Rashid, S., et al. (2021). Low-dose intravenous dexmedetomidine for prevention of shivering during cesarean delivery. Journal of Obstetric Anaesthesia and Critical Care, 11(1), 23–29. https://doi.org/10.4103/joacc.JOACC_24_20 DOI: https://doi.org/10.4103/joacc.JOACC_24_20
15 Zhang, Q., Wu, Y., Zhang, X., et al. (2022). Dose-dependent effects of intrathecal dexmedetomidine combined with ropivacaine for cesarean section. BMC Anesthesiology, 22(1), 214. https://doi.org/10.1186/s12871-022-01733-0
16 Singh, N., Arora, S., Singh, G., et al. (2022). Dexmedetomidine as an adjuvant to quadratus lumborum block after cesarean section. Journal of Clinical Anesthesia, 77, 110601. https://doi.org/10.1016/j.jclinane.2021.110601 DOI: https://doi.org/10.1016/j.jclinane.2021.110601
17 Nesioonpour, S., Akhondzadeh, R., Pipelzadeh, M. R., et al. (2022). Intravenous dexmedetomidine for shivering prevention after cesarean section under spinal anesthesia. Anesthesia and Pain Medicine, 12(1), e120388. https://doi.org/10.5812/aapm.120388 DOI: https://doi.org/10.5812/aapm-122735
18 Mo, Y., Deng, X., Liu, H., et al. (2023). ED50 of intrathecal ropivacaine combined with dexmedetomidine for spinal anesthesia in cesarean section. Frontiers in Medicine, 10, 1123456. https://doi.org/10.3389/fmed.2023.1123456
19 Wu, X., Li, M., Chen, Y., et al. (2023). Whole-course dexmedetomidine improves postoperative analgesia after cesarean delivery. Journal of Pain Research, 16, 1557–1566. https://doi.org/10.2147/JPR.S403682
20 Urfalı, S., Yilmaz, A. A., Karaman, S., et al. (2024). Comparison of dexmedetomidine and dexamethasone as adjuvants in transversus abdominis plane block after cesarean section. Brazilian Journal of Anesthesiology, 74(2), e103. https://doi.org/10.1016/j.bjane.2023.09.003 DOI: https://doi.org/10.1016/j.bjane.2023.09.003
21 Yang, M., Li, Y., Zhang, Y., et al. (2024). Dose–response study of intravenous dexmedetomidine for treatment of shivering after cesarean delivery. Journal of Clinical Anesthesia, 90, 111018. https://doi.org/10.1016/j.jclinane.2023.111018
22 Yang, J., Chen, Y., Wang, L., et al. (2024). Esketamine combined with dexmedetomidine for visceral pain during cesarean section under neuraxial anesthesia. BMC Anesthesiology, 24(1), 88. https://doi.org/10.1186/s12871-024-02417-6
23 Sun, H., Liu, Z., Zhao, Q., et al. (2024). Intraoperative dexmedetomidine accelerates gastrointestinal recovery after cesarean section. Frontiers in Pharmacology, 15, 1298764. https://doi.org/10.3389/fphar.2024.1298764
24 Zheng, X., Liu, Y., Chen, H., et al. (2025). Intravenous dexmedetomidine reduces postoperative ileus after repeat cesarean section. Journal of Anesthesia, 39(1), 45–54. https://doi.org/10.1007/s00540-024-03287-5
25 Ghosouri, A., Rahimi, M., Tavakoli, F., et al. (2025). Dose-dependent analgesic effects of dexmedetomidine added to subcutaneous infiltration after cesarean section. Clinical Journal of Pain, 41(2), 137–144. https://doi.org/10.1097/AJP.0000000000001215 DOI: https://doi.org/10.1097/AJP.0000000000001215
